Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Ltd reported revenue of 77.2M USD for the year ending 31 December 2025, up 9.2% from 70.7M a year earlier.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in USD.
| Figure | Period | Amount | Year on year |
|---|
| Revenue |
2025 · ending 31 December 2025 |
77.2M |
+9.2% |
| Gross Profit |
2025 · ending 31 December 2025 |
57.6M |
+16.0% |
| Operating Income |
2025 · ending 31 December 2025 |
-7.8M |
— |
| Net Income |
2025 · ending 31 December 2025 |
-7.9M |
— |
| Cost of Revenue |
2025 · ending 31 December 2025 |
19.5M |
-7.0% |
| Operating Cash Flow |
2025 · ending 31 December 2025 |
-4.1M |
— |
| Free Cash Flow |
2025 · ending 31 December 2025 |
-4.8M |
— |
| EPS |
2021 · ending 31 December 2021 |
0.00 |
— |
Revenue and profit by financial year
As filed, in USD. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
|---|
| 2025 | 2025-12-31 |
77.2M | -7.8M | -7.9M | -4.8M |
|---|
| 2024 | 2024-12-31 |
70.7M | -49M | -47.5M | -13.4M |
|---|
| 2023 | 2023-12-31 |
75.7M | -94.3M | -92.1M | -37.2M |
|---|
| 2022 | 2022-12-31 |
81.7M | -142.1M | -140.8M | -75.2M |
|---|
| 2021 | 2021-12-31 |
79.7M | -125.1M | -125M | -107.1M |
|---|
| 2020 | 2020-12-31 |
65.9M | -63.2M | -62.4M | -20.5M |
|---|
Every period
Revenue Annual
| Period | Ending | Revenue |
|---|
| FY25 | 2025-12-31 | 77.2M |
|---|
| FY24 | 2024-12-31 | 70.7M |
|---|
| FY23 | 2023-12-31 | 75.7M |
|---|
| FY22 | 2022-12-31 | 81.7M |
|---|
| FY21 | 2021-12-31 | 79.7M |
|---|
Gross Profit Annual
| Period | Ending | Gross Profit |
|---|
| FY25 | 2025-12-31 | 57.6M |
|---|
| FY24 | 2024-12-31 | 49.6M |
|---|
| FY23 | 2023-12-31 | 51.2M |
|---|
| FY22 | 2022-12-31 | 55.1M |
|---|
| FY21 | 2021-12-31 | 57.1M |
|---|
Operating Income Annual
| Period | Ending | Operating Income |
|---|
| FY25 | 2025-12-31 | -7.8M |
|---|
| FY24 | 2024-12-31 | -49M |
|---|
| FY23 | 2023-12-31 | -94.3M |
|---|
| FY22 | 2022-12-31 | -142.1M |
|---|
| FY21 | 2021-12-31 | -125.1M |
|---|
Net Income Annual
| Period | Ending | Net Income |
|---|
| FY25 | 2025-12-31 | -7.9M |
|---|
| FY24 | 2024-12-31 | -47.5M |
|---|
| FY23 | 2023-12-31 | -92.1M |
|---|
| FY22 | 2022-12-31 | -140.8M |
|---|
| FY21 | 2021-12-31 | -125M |
|---|
Cost of Revenue Annual
| Period | Ending | Cost of Revenue |
|---|
| FY25 | 2025-12-31 | 19.5M |
|---|
| FY24 | 2024-12-31 | 21M |
|---|
| FY23 | 2023-12-31 | 24.5M |
|---|
| FY22 | 2022-12-31 | 26.6M |
|---|
| FY21 | 2021-12-31 | 22.6M |
|---|
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
|---|
| FY25 | 2025-12-31 | -4.1M |
|---|
| FY24 | 2024-12-31 | -12.6M |
|---|
| FY23 | 2023-12-31 | -36M |
|---|
| FY22 | 2022-12-31 | -66.2M |
|---|
| FY21 | 2021-12-31 | -75M |
|---|
Free Cash Flow Annual
Operating cash flow minus capital expenditure.
| Period | Ending | Free Cash Flow |
|---|
| FY25 | 2025-12-31 | -4.8M |
|---|
| FY24 | 2024-12-31 | -13.4M |
|---|
| FY23 | 2023-12-31 | -37.2M |
|---|
| FY22 | 2022-12-31 | -75.2M |
|---|
| FY21 | 2021-12-31 | -107.1M |
|---|
EPS Annual
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.
| Period | Ending | EPS |
|---|
| FY21 | 2021-12-31 | 0.00 |
|---|
| FY20 | 2020-12-31 | 0.00 |
|---|